Author:
Adel Tameem,Cohen Taco,Caan Matthan,Welling Max
Funder
NWO IPPSI-KIEM
SURF Foundation
Nuts-OHRA Foundation
Netherlands Organisation for Health Research and Development
AIDS Fonds
Gilead Sciences
ViiV Healthcare
Janssen Pharmaceutica N.V.
Bristol-Myers Squibb
Boehringer Ingelheim
Merck&Co
Alzheimer's Disease Neuroimaging Initiative
National Institutes of Health
DOD
ADNI
Department of Defense
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
Foundation for the National Institutes of Health
Subject
Cognitive Neuroscience,Clinical Neurology,Neurology,Radiology Nuclear Medicine and imaging
Reference49 articles.
1. Single subject prediction of brain disorders in neuroimaging: promises and pitfalls;Arbabshirani;Neuroimage,2016
2. Mathematical Methods for Physicists;Arfken,1985
3. Precuneus and cingulate cortex atrophy and hypometabolism in patients with Alzheimer's disease and mild cognitive impairment: MRI and 18 f-FDG PET quantitative analysis using freesurfer;Bailly;Biomed. Res. Int.,2015
4. Searching for exotic particles in high-energy physics with deep learning;Baldi;Nat. Commun.,2014
5. Hierarchical Neural Networks for Image Interpretation;Behnke,2003